BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23481058)

  • 1. Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys.
    Hung TW; Liou JH; Yeh KT; Tsai JP; Wu SW; Tai HC; Kao WT; Lin SH; Cheng YW; Chang HR
    Indian J Med Res; 2013 Jan; 137(1):102-10. PubMed ID: 23481058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease.
    Luo R; Zhang W; Zhao C; Zhang Y; Wu H; Jin J; Zhang W; Grenz A; Eltzschig HK; Tao L; Kellems RE; Xia Y
    Hypertension; 2015 Jul; 66(1):75-84. PubMed ID: 25987665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of hypoxia-inducible factor-1α gene attenuates chronic ischemic renal injury in two-kidney, one-clip rats.
    Wang Z; Zhu Q; Li PL; Dhaduk R; Zhang F; Gehr TW; Li N
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1236-42. PubMed ID: 24623146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-1α mediates the profibrotic effect of albumin in renal tubular cells.
    Hu J; Wang W; Zhang F; Li PL; Boini KM; Yi F; Li N
    Sci Rep; 2017 Nov; 7(1):15878. PubMed ID: 29158549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia].
    Shvetsov MIu; Ivanov AA; Kuznetsova AV; Popova OP; Rameeva AS
    Ter Arkh; 2009; 81(8):14-9. PubMed ID: 19799194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hypoxia-inducible factor-1α and hepatocyte growth factor in development of fibrosis in the transplanted kidney.
    Kellenberger T; Marcussen N; Nyengaard JR; Wogensen L; Jespersen B
    Transpl Int; 2015 Feb; 28(2):180-90. PubMed ID: 25284705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease.
    Thomas JL; Pham H; Li Y; Hall E; Perkins GA; Ali SS; Patel HH; Singh P
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F282-F290. PubMed ID: 28331062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist is a new prognostic marker for renal survival in patients with chronic kidney disease.
    Sun S; Du R; Xia L; Sun W; Zhai Y; Yu Y; Zhao A; Huang C; Ning X; Wang H
    Am J Nephrol; 2012; 35(2):141-51. PubMed ID: 22248584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hypoxia-inducible factor-1α (HIF-1α) in infiltrating inflammatory cells is associated with chronic allograft dysfunction and predicts long-term graft survival.
    Yu TM; Wen MC; Li CY; Cheng CH; Wu MJ; Chen CH; Shu KH
    Nephrol Dial Transplant; 2013 Mar; 28(3):659-70. PubMed ID: 23028107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats.
    Zhu Q; Wang Z; Xia M; Li PL; Van Tassell BW; Abbate A; Dhaduk R; Li N
    Hypertension; 2011 Oct; 58(4):657-64. PubMed ID: 21896938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney injury is independent of endothelial HIF-1α.
    Kalucka J; Schley G; Georgescu A; Klanke B; Rössler S; Baumgartl J; Velden J; Amann K; Willam C; Johnson RS; Eckardt KU; Weidemann A
    J Mol Med (Berl); 2015 Aug; 93(8):891-904. PubMed ID: 25754172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of HIF-1α on renal fibrosis in cisplatin-induced chronic kidney disease.
    Zhao H; Han Y; Jiang N; Li C; Yang M; Xiao Y; Wei L; Xiong X; Yang J; Tang C; Xiao L; Liu F; Liu Y; Sun L
    Clin Sci (Lond); 2021 May; 135(10):1273-1288. PubMed ID: 33997886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway.
    Shao Y; Lv C; Wu C; Zhou Y; Wang Q
    Diabetes Metab Res Rev; 2016 Sep; 32(6):534-43. PubMed ID: 26891083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.
    Fang Y; Yu X; Liu Y; Kriegel AJ; Heng Y; Xu X; Liang M; Ding X
    Am J Physiol Renal Physiol; 2013 May; 304(10):F1274-82. PubMed ID: 23467423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan alleviates renal fibrosis by down-regulating HIF-1α and up-regulating MMP-9/TIMP-1 in rats with 5/6 nephrectomy.
    Fu W; Wang Y; Jin Z; Wang H; Cheng W; Zhou H; Yin P; Peng W
    Ren Fail; 2012; 34(10):1297-304. PubMed ID: 23006043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α).
    Sun C; Song H; Zhang H; Hou C; Zhai T; Huang L; Zhang L
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1619-24. PubMed ID: 22614155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.
    Baumann B; Hayashida T; Liang X; Schnaper HW
    Kidney Int; 2016 Oct; 90(4):797-808. PubMed ID: 27503806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.
    Kimura K; Iwano M; Higgins DF; Yamaguchi Y; Nakatani K; Harada K; Kubo A; Akai Y; Rankin EB; Neilson EG; Haase VH; Saito Y
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1023-9. PubMed ID: 18667485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.
    Higgins DF; Kimura K; Bernhardt WM; Shrimanker N; Akai Y; Hohenstein B; Saito Y; Johnson RS; Kretzler M; Cohen CD; Eckardt KU; Iwano M; Haase VH
    J Clin Invest; 2007 Dec; 117(12):3810-20. PubMed ID: 18037992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.